
    
      A randomized, double-blind, parallel group, placebo and active (prednisone) controlled,
      6-week study of the effect of GW685698X aqueous nasal spray 100mcg QD on the hypothalamic
      pituitary adrenocortical (HPA) axis in adolescents and adults 12 to 65 years of age with
      perennial allergic rhinitis (PAR).
    
  